| Literature DB >> 26062801 |
Gemma Clarke1, Sarah Galbraith2, Jeremy Woodward3, Anthony Holland4, Stephen Barclay5.
Abstract
BACKGROUND: Some people with progressive neurological diseases find they need additional support with eating and drinking at mealtimes, and may require artificial nutrition and hydration. Decisions concerning artificial nutrition and hydration at the end of life are ethically complex, particularly if the individual lacks decision-making capacity. Decisions may concern issues of life and death: weighing the potential for increasing morbidity and prolonging suffering, with potentially shortening life. When individuals lack decision-making capacity, the standard processes of obtaining informed consent for medical interventions are disrupted. Increasingly multi-professional groups are being utilised to make difficult ethical decisions within healthcare. This paper reports upon a service evaluation which examined decision-making within a UK hospital Feeding Issues Multi-Professional Team.Entities:
Mesh:
Year: 2015 PMID: 26062801 PMCID: PMC4462006 DOI: 10.1186/s12910-015-0034-8
Source DB: PubMed Journal: BMC Med Ethics ISSN: 1472-6939 Impact factor: 2.652
Cross-tabulation illustrating a model of the process of FIMPT decision-making based on a three month non-participant observation
| Decision stage | Observation | Description |
|---|---|---|
| 0. Before the meeting | Not observed | Patient referred from ward or community. Depending upon time of admission and time of referral: the dietician, speech and language therapist, gastroenterologist and other relevant specialists assess the patient. Decision-making capacity is assessed. Treatment options are talked over and explained with the patient and/or next of kin. |
| 1. Forming the picture | Observed | Background information about the patient’s case is presented by member of the clinical team who knows the patient. Dietetics and speech & language therapy present the results from their assessments |
| 2. Identifying the problem | Observed | If the reasons for the patient’s referral are apparent and their diagnosis is clear, the discussion can move straight onto stage 3. In complex cases, the Chair and other participants will ask further questions of the person presenting the case, the speech and language therapist, dietician and anyone else who has examined the patient. |
| 3. Discussion | Observed | A deeper conversation about potential treatments and interventions. Conversation seeks to balance risks and benefits, other clinical issues, and includes ethical and social concerns. At this stage, the discussion has a less structured format. Stage 3 continues until the weight of evidence for a particular treatment option or course of action becomes apparent. |
| 4. Outcome and planning | Observed | The Chair states the outcome of decision-making process and a brief discussion of treatment scheduling and planning follows. For some patients the outcome involves direct patient assessment by one of the FIMPT clinicians, this may include referral to palliative care or medicine for the elderly teams to assist in all future management not only management of nutrition. |
| 5. After the meeting | Not observed | The recommendations from the meeting are presented back to the patient and/or next of kin by the treating team who have presented the patient at the meeting. Further discussions and decision-making take place. Relevant scheduling and planning takes place. The treating team return to the next meeting for further discussion if additional questions arise or if the patient’s condition changes. |
Cross-tabulation illustrating a model of the decision-making axes upon which clinical information was weighted to make decisions
| Decision-making axes | Description |
|---|---|
| Risks, burdens and benefits | Comparison and weighting of the different treatment options and interventions by their potential effectiveness, dangers, outcomes and side-effects. |
| Treatment goals | The intended outcome, either specific to a particular treatment/interventions, place (institution/home) for future care for the patient or the overall intended outcome. |
| Normative ethical values | A balancing of actions in terms of ethical value. Actions in terms of their utilitarian value, i.e., increasing patient well-being and/or longevity; and deontological value, i.e., it was a ‘good’ course of action regardless of outcome. |
| Interested parties | Discussions incorporated the views of all involved stakeholders, which could include: the patient or their previous wishes, clinical team, relatives, etc. |